ARTICLE 64 FEED & ADDITIVE MAGAZINE March 2026 France (especially Brittany) hosts pilot projects exploring Ulva, Palmaria, and Laminaria for aquafeed and livestock, aiming to localize supply and promote sustainable sourcing. Asia remains a largescale producer of Laminaria and related species, primarily for human food but increasingly investigated for feed use. TECHNICAL CHALLENGES OF MACROALGAE IN ANIMAL NUTRITION Despite promising benefits, several hurdles limit the widespread adoption of macroalgae in feed. A primary challenge is the variability of algae composition, which fluctuates with species, season, harvest method, and geographic origin. This variability affects the concentration of key bioactives and minerals, complicating formulation and consistent efficacy. Contaminant risk is another critical concern. Macroalgae can accumulate heavy metals, iodine in excess, and undesirable halogenated compounds. For instance, Asparagopsis contains bromoform, which, while effective for methane mitigation, raises food safety and regulatory scrutiny, necessitating precise dosing and monitoring. Stability and bioavailability of algae bioactives during feed processing and digestion also pose significant challenges. Many active compounds degrade under heat, pressure, or extended storage. Furthermore, their release and activity in the gut environment are often unpredictable, undermining functional benefits. Sometimes, the natural composition of certain macroalgae necessitates high inclusion rates in animal feed formulations to achieve the desired functional benefits. This can pose economic challenges for formulators, as using large quantities of algae increases feed costs significantly. Moreover, high inclusion levels may negatively impact the palatability of the feed, causing animals to reduce their intake or reject the feed altogether. These factors create important considerations when integrating algae-based ingredients into commercial feed formulations. To address these issues, recent research focuses on advanced analytical methods to identify and quantify specific algae metabolites - so-called “phycogenics” - enabling targeted selection of strains and harvest conditions to optimize functional compound profiles. This screening accelerates product standardization and efficacy assurance. Emerging micro-encapsulation technologies are also being explored to protect sensitive algae compounds during feed processing and storage, and to control their release in specific gut regions. Encapsulation improves stability and enhances bioactivity, making algae-based additives more reliable and potent. An exciting frontier lies in fermentation and bioprocessing approaches that do not merely preserve but enhance the physiological activity of algae compounds. Controlled microbial fermentation can increase bioavailability, reduce unwanted compounds, and potentially produce novel metabolites with enhanced immunomodulatory or antioxidant properties. MARKET OUTLOOK: BRIDGING TODAY’S REALITY AND TOMORROW’S POTENTIAL Currently, marine macroalgae in animal feed represent a fragmented and emerging market, with aggregate sales estimated between USD 70 and 120 million. Immune modulation and gut health products lead today’s revenue, followed by antioxidant support and mineral supplementation. Methane mitigation, flavor enhancement, and sustainable fiber applications remain smaller but are evolving quickly. Looking ahead, the market’s future value is forecasted around USD 1.25 billion, propelled by growing demand for natural, sustainable feed solutions that align with climate goals and consumer preferences. Among these, methane mitigation technology based on algae such as Asparagopsis taxiformis holds enormous potential due to its capacity to reduce enteric methane emissions by up to 80%. However, this promise comes with significant technical challenges. The production of Asparagopsis at commer-
RkJQdWJsaXNoZXIy MTUxNjkxNQ==